Drug interactions
Hydroxyprogesterone caproate + Linagliptin-metformin
Severity: Minor
Hydroxyprogesterone caproate and Linagliptin-metformin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Progestins can cause some reduction in glucose tolerance. Hydroxyprogesterone caproate may therefore slightly weaken glycemic control in patients taking antidiabetic medicines.
What this interaction means in plain words
Hydroxyprogesterone caproate and Linagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Progestogenic effects may modestly increase insulin resistance.
What to do
Monitor blood glucose when starting or stopping treatment and adjust antidiabetic doses only if control changes.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Hydroxyprogesterone caproate and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Frequently asked questions
Can I take Hydroxyprogesterone caproate with Linagliptin-metformin?
MediHelp rates the interaction as minor. Hydroxyprogesterone caproate and Linagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Progestins can cause some reduction in glucose tolerance. Hydroxyprogesterone caproate may therefore slightly weaken glycemic control in patients taking antidiabetic medicines.
How serious is the interaction between Hydroxyprogesterone caproate and Linagliptin-metformin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or stopping treatment and adjust antidiabetic doses only if control changes.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
